BIA
IRWD icon

Bell Investment Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bell Investment Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-48
Closed -$63 – 1870
2025
Q3 		$63 Hold
48
– – ﹤0.01% 1866
2025
Q2 		$35 Hold
48
– – ﹤0.01% 1872
2025
Q1 		$71 Hold
48
– – ﹤0.01% 1890
2024
Q4 		$213 Sell
48
-168
-78% -$682 ﹤0.01% 1870
2024
Q3 		$890 Hold
216
– – ﹤0.01% 1628
2024
Q2 		$1.41K Hold
216
– – ﹤0.01% 1493
2024
Q1 		$1.88K Hold
216
– – ﹤0.01% 1385
2023
Q4 		$2.47K Hold
216
– – ﹤0.01% 1239
2023
Q3 		$2.08K Sell
216
-69
-24% -$676 ﹤0.01% 1259
2023
Q2 		$3.03K Buy
285
+142
+99% +$1.53K ﹤0.01% 1085
2023
Q1 		$1.5K Buy
143
+2
+1% +$22 ﹤0.01% 1399
2022
Q4 		$1.75K Sell
141
-2
-1% -$23 ﹤0.01% 1361
2022
Q3 		$1K Buy
143
+50
+54% +$567 ﹤0.01% 1447
2022
Q2 		$1K Buy
+93
New +$1.1K ﹤0.01% 1466
2021
Q4 		$1K Sell
49
-39
-44% -$478 ﹤0.01% 1476
2021
Q3 		$1K Buy
+88
New +$1.14K ﹤0.01% 1422

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bell Investment Advisors's IRWD Position: Q4 2025 in Review

Bell Investment Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2025, closing a stake of 48 shares — an estimated $63 sold.

Bell Investment Advisors first reported a position in IRWD in Q3 2021 and held it in 16 quarters. The position peaked at $3.03K in Q2 2023. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.

  • Bell Investment Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 48 Ironwood Pharmaceuticals shares in Q4 2025, an estimated $63.
  • Bell Investment Advisors first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 16 quarters.
  • Bell Investment Advisors's Ironwood Pharmaceuticals position peaked at $3.03K in Q2 2023.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.

Based on Bell Investment Advisors's 13F filing for Q4 2025, filed 24 Feb 2026.